Insulin Adverse Events.
Adverse events
Cancer
Hypoglycemia
Insulin
Insulin allergy
Insulin antibodies
Lipo-atrophy
Lipo-hypertrophy
Obesity
Journal
Pediatric endocrinology reviews : PER
ISSN: 1565-4753
Titre abrégé: Pediatr Endocrinol Rev
Pays: Israel
ID NLM: 101202124
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
entrez:
26
3
2020
pubmed:
26
3
2020
medline:
6
5
2020
Statut:
ppublish
Résumé
The negative consequencies of diabetes treatment are traditionally regarded as caused by a disastrous treatment rather than adverse events of the insulin preparations. However, hypoglycemia, changes at the injection site (lipatrophy, lipoma), insulin allergy, obesity and increased risk of certain forms of cancer can easily be regarded as adverse events of the drug, and needle-phobia, psychological problems, increased risk of suicide are adverse events related to insulin and its administration. Also macroangiopathy and even microangiopathy to some extent can be regarded as adverse events as the most crucial part of the treatment of Type 1 diabetes is the insulin treatment. There is still room for improvments of insulin as a drug. We need insulins with more predictable absorption and kinetics, leading to more stable near-normal blood glucose, less risk of hypoglycemia, less effect in periphery and more effect on the liver, and less risk of vascular complications, obesity, cancer.
Identifiants
pubmed: 32208562
doi: 10.17458/per.vol17.2020.l.insulinadverseevents
doi:
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Insulin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
183-190Informations de copyright
Copyright© of YS Medical Media ltd.